Skip to main content

Table 2 Univariate analysis of overall survival in patients with KTs of colorectal origin

From: Clinical analysis of Krukenberg tumours in patients with colorectal cancer—a review of 57 cases

 

Median

95% confidence interval

P value (log-rank)

Age at diagnosis of KT

0.979

 <60 years

36

27.546, 44.454

 ≥60 years

31

26.394, 35.606

Menses

0.425

 Pre-menopausal

35

27.302, 42.698

 Post-menopausal

38

26.016, 49.984

Timing of ovarian metastases

0.027

 Synchronous

31

3.592, 58.408

 13–24 months

35

28.196, 41.804

 >24 months

54

37.622, 70.378

Tumour size

0.256

 ≤10 cm

36

30.511, 41.489

 >10 cm

20

2.402, 37.598

Status of ovarian involvement

0.570

 Unilateral

35

25.783, 44.217

 Bilateral

36

25.828, 46.172

Extent of metastatic disease

<0.001

M ovary

54

35.028, 72.972

 M1

35

20.868, 49.132

 M2

13

10.608, 15.392

Extent of surgery

0.224

 Minimal

32

12.493,51.507

 Extensive

38

29.071, 46.929

Completeness of cytoreduction

<0.001

 CC0

56

46.082, 58.200

 CC1

28

10.066, 45.934

 CC2

13

7.951, 18.049

Systemic chemotherapy

0.006

 Yes

47

34.992, 59.008

 No

30

8.932, 51.068

Depth of tumour invasion

0.117

 T3

39

33.234, 44.766

 T4

30

15.296, 44.704

Lymph node metastasis

0.011

 Retroperitoneal lymph node metastasis

18

9.363, 26.637

 Non-retroperitoneal lymph node metastasis

36

19.390, 58.610

 None

39

27.484, 50.516

  1. Note: CC0 and CC1 are described as complete cytoreduction, CC2 as incomplete cytoreduction
  2. CC0 no macroscopic residual tumour, CC1 maximal diameter of residual tumour <2.5 mm, CC2 maximal diameter of residual tumour ≥2.5 mm, M ovary ovary-only metastasis, M1 metastasis confined to the pelvis, M2 metastasis beyond the pelvis